Metabolic profiling detects field effects in nondysplastic tissue from esophageal cancer patients

Doctor's notes

The variable rate of missed cancer in endoscopic biopsies and lack of other biomarkers reduce the effectiveness of surveillance programs in esophageal cancer. Based on the “field cancerization” hypothesis that tumors arise within a transformed field with an altered biochemical phenotype, we sought to test if metabolic profiling could differentiate between histologically normal tissue from […]

Repeatability of the measurement of exhaled volatile metabolites using selected ion flow tube mass spectrometry

Selected ion flow tube mass spectrometry, SIFT-MS, has been used to determine the repeatability of the analysis of volatile metabolites within the breath of healthy volunteers, with emphasis on the influence of sampling methodology. Baseline instrument specific coefficients of variability for examined metabolites were as follows: acetone (1%), ammonia (1%), isoprene (2%), propanol (6%), ethanol […]

A Complete Pipeline for Untargeted Urinary Volatolomic Profiling with Sorptive Extraction and Dual Polar and Nonpolar Column Methodologies Coupled with Gas Chromatography Time-of-Flight Mass Spectrometry

GP practice setting

Volatolomics offers an opportunity for noninvasive detection and monitoring of human disease. While gas chromatography-mass spectrometry (GC-MS) remains the technique of choice for analyzing volatile organic compounds (VOCs), barriers to wider adoption in clinical practice still exist, including: sample preparation and introduction techniques, VOC extraction, throughput, volatolome coverage, biological interpretation, and quality control (QC).

Diagnostic Performance of a Noninvasive Breath Test for Colorectal Cancer: COBRA1 Study

Breath test in a GP office with a consultant

Colorectal cancer (CRC) is the third most common cancer globally.1 When diagnosed early, the 5-year survival rate is 92%,2 yet 23% of CRCs are diagnosed at an advanced stage3 in the United Kingdom with a 5-year survival rate of 10%.2 Early CRC has symptoms that are shared with common benign conditions.4 Colonoscopy capacity is limited, and referring all symptomatic […]